Given the crucial role of this cell type in the defense against HSV, early establishment of CD8+ T cell responses has been explored as a means of preventing establishment of latency; however, this therapeutic strategy has proved less promising in animal models, which establish a latent infection despite lower viral copy numbers in neural sites as well as decreased viral titers at the site of infection [168]. Here, CD8A is linked to infection.